Results 201 to 210 of about 329,486 (286)
<i>Helicobacter pylori</i> Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions. [PDF]
Chen X +5 more
europepmc +1 more source
This study presents a modular redox‐responsive nanocapsule platform that enables enhanced tumor‐targeted delivery of antimicrobial peptides. Using melittin as an example, the system achieves controlled activation within the tumor microenvironment, improving intratumoral accumulation while minimizing systemic toxicity.
Lin Tang +9 more
wiley +1 more source
Nonadherence to Antiviral Therapy Leading to Severe Hepatic Decompensation in a Patient With Chronic Hepatitis B. [PDF]
Ahmad S +9 more
europepmc +1 more source
Dendrite Formation and Self‐Healing Mechanism in Ionic Liquid‐Based Magnesium Batteries
This graphical illustration highlights the importance of operating Mg batteries within a safe operating current density (SOCD) range. Beyond this range, Mg batteries are susceptible to dendrite formation. However, when cycling a dendritic cell with a highly thermally stable electrolyte, a self‐heating effect occurs.
Omar W. Elkhafif +5 more
wiley +1 more source
mGem: Deciphering how polyomaviruses coexist with their hosts for a lifetime. [PDF]
Pipas JM, Sullivan CS.
europepmc +1 more source
Degradation Pathways of Silicon‐Based Anodes in Lithium‐Ion Batteries
Silicon‐based anodes undergo degradation through five primary pathways: (1) mechanical and structural deterioration of the active material, (2) loss of electrode integrity and electrical contact, (3) mechanical instability of the solid electrolyte interphase (SEI), characterized by repetitive fracture and deformation, (4) chemical instability of the ...
Yoon Jeong Choi +3 more
wiley +1 more source
Risk factors associated with cytomegalovirus reactivation and disease in critically-ill COVID-19 and non-COVID-19 patients, concomitantly admitted to intensive care. [PDF]
Korem M +8 more
europepmc +1 more source
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi +4 more
wiley +1 more source

